We found that inhibition of ERK1/2, serine proteases and cathepsin B, but not p38, NF-κB and PKC, resulted in significantly lower IL-1β release compared to DMSO treated cells after CFT073 infection at MOI 1 for 6h. The gene discussed is MAPK3; the disease is infection.